Harbour Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,405
Closed -$1.56M 288
2024
Q1
$1.56M Sell
11,405
-265
-2% -$33.3K 0.39% 58
2023
Q4
$1.4M Sell
11,670
-225
-2% -$23K 0.38% 61
2023
Q3
$1.11M Buy
11,895
+1,255
+12% +$141K 0.33% 72
2023
Q2
$1.35M Sell
10,640
-112
-1% -$13.5K 0.4% 58
2023
Q1
$1.25M Buy
10,752
+3,760
+54% +$421K 0.38% 67
2022
Q4
$802K Buy
6,992
+3,257
+87% +$358K 0.27% 90
2022
Q3
$374K Buy
+3,735
New +$316K 0.13% 151

Other funds holding DXCM

Harbour Capital Advisors's DXCM Position: Q2 2024 in Review

Harbour Capital Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 11,405 shares — an estimated $1.56M sold.

Harbour Capital Advisors first reported a position in DXCM in Q3 2022 and held it in 7 quarters. The position peaked at $1.56M in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Harbour Capital Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Harbour Capital Advisors sold 11,405 DexCom shares in Q2 2024, an estimated $1.56M.
  • Harbour Capital Advisors first reported a position in DexCom in Q3 2022 and held it in 7 quarters.
  • Harbour Capital Advisors's DexCom position peaked at $1.56M in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Harbour Capital Advisors's 13F filing for Q2 2024, filed 12 Jul 2024.